Going to incredible lengths LEARN MORE SEE MORE Company We’re Horizon, a global biotechnology company driven by a simple idea: we believe that science and compassion must work together to transform lives. SEE MORE Pipeline Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. SEE MORE Medicines We’re driven by a clear purpose: to improve patients’ lives. And the clearest expression of that purpose is the portfolio of medicines we offer to treat rare, autoimmune and severe inflammatory diseases. SEE MORE Anti-Racism At Horizon, we stand firmly against inequality in all forms, including racism, hate, religious intolerances and discrimination based on gender identity or sexual orientation. Read our statement here. SEE MORE News 11/22/2021 New Analysis Published in Multiple Sclerosis and Related Disorders Supports the Efficacy of UPLIZNA® (inebilizumab-cdon) in Patients Previously Treated with Rituximab for Neuromyelitis Optica Spectrum Disorder (NMOSD) 11/15/2021 Horizon Therapeutics Recognizes Second Annual Thyroid Eye Disease (TED) Awareness Week with New Educational and Community Building Initiative SEE MORE Our CompanyOur ScienceOur MedicinesOur PatientsCareersInvestors Follow Us © 2021 Horizon Therapeutics plc Global Privacy PolicyLegal NoticeCookie PolicyContact Us The information regarding our medicines and the patients they treat on this site is intended only for residents of the U.S. About Cookies On This Site We use cookies to personalize and enhance your experience on our site. Visit our Privacy Policy to learn more or manage your personal preferences in our Cookie Consent Tool. By using our site, you agree to our use of cookies. Accept Options